Inventor · Boston, MA, US

Harvey Cantor

20Patents
7h-index
17Co-inventors
66Inventor score

Filing activity: Oct 20, 1982 → Feb 27, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US5049659A Proteins which induce immunological effector cell activation and chemattraction Human Necessities 70 Expired
US4559310A Assay methods and systems utilizing mast cell clones Emerging Cross-Sectional Technologies 22 Expired
US5238839A Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells Chemistry; Metallurgy 18 Expired
US4613459A Lymphocyte growth factor Human Necessities 12 Expired
US4722998A Method of producing lymphocyte growth factors Emerging Cross-Sectional Technologies 9 Expired
US9944931B2 Methods and compositions for reducing immunosupression by tumor cells Chemistry; Metallurgy 9 Active
US4952499A Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses Chemistry; Metallurgy 7 Expired
US10548957B2 Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis Chemistry; Metallurgy 6 Active
US4720482A Pharmaceutical compositions containing one or more lymphocyte growth factors Human Necessities 6 Expired
US10876120B2 Methods and compositions for reducing immunosupression by tumor cells Chemistry; Metallurgy 4 Active
US10596195B2 Discovery of regulatory T cells programmed to suppress an immune response Chemistry; Metallurgy 3 Active
US11597934B2 Methods and compositions for reducing immunosuppression by tumor cells Chemistry; Metallurgy 2 Active
US6472170B1 BCL-XY, a novel BCL-X isoform, and uses related thereto Chemistry; Metallurgy 1 Expired
US5149785A Proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses Chemistry; Metallurgy 1 Expired
US11371989B2 Intracellular osteopontin regulates the lineage commitment of lymphoid subsets Physics 0 Active
US12202904B2 IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells Physics 0 Active
US11591403B2 IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells Physics 0 Active
US8197817B2 Regulation of mink in thymocytes and T lymphocytes Chemistry; Metallurgy 0 Active
US11590213B2 Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis Chemistry; Metallurgy 0 Active
US7160986B2 BCL-xγ, a novel BCL-x isoform, and uses related thereto Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.